Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02

Manmeet Ahluwalia

Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02

Manmeet Ahluwalia

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	20
State	Published - Oct 28 2018

Access to Document

ViewcontentFinal published version, 20.4 KBLicense: Unspecified

Cite this

@article{0ad5e997d18f40648ff5c5885d17dbe7,

title = "Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02",

author = "Manmeet Ahluwalia",

note = "Neuro-Oncology (2018) 20(4):546-556",

year = "2018",

month = oct,

day = "28",

language = "American English",

volume = "20",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02

AU - Ahluwalia, Manmeet

N1 - Neuro-Oncology (2018) 20(4):546-556

PY - 2018/10/28

Y1 - 2018/10/28

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/4194

M3 - Article

VL - 20

JO - Neuro-oncology

JF - Neuro-oncology

ER -

Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02

Access to Document

Other files and links

Cite this